These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1574962)

  • 1. Current and potential applications for erythropoietin.
    Pedrazzini A
    Acta Haematol; 1992; 87 Suppl 1():2-3. PubMed ID: 1574962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
    Winearls CG
    Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and the anaemia of chronic disease.
    Krantz SB
    Nephrol Dial Transplant; 1995; 10 Suppl 2():10-7. PubMed ID: 7644100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-- measurement and clinical applications.
    Marsden JT
    Ann Clin Biochem; 2006 Mar; 43(Pt 2):97-104. PubMed ID: 16536911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
    Abels RI
    Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyporesponsiveness to recombinant human erythropoietin.
    Drüeke T
    Nephrol Dial Transplant; 2001; 16 Suppl 7():25-8. PubMed ID: 11590253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of renal anemia with erythropoietin].
    Spustova V; Kovac A
    Bratisl Lek Listy; 1999 Aug; 100(8):432-8. PubMed ID: 10645031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous.
    Hörl WH
    Acta Haematol; 1992; 87 Suppl 1():16-9. PubMed ID: 1574961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
    Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
    J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
    Phibbs RH; Shannon KM; Mentzer WC
    Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and erythropoietin treatment in chronic kidney diseases.
    Santoro A; Canova C
    Minerva Urol Nefrol; 2005 Mar; 57(1):23-31. PubMed ID: 15944519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin.
    Macdougall IC; Davies ME; Hutton RD; Coles GA; Williams JD
    Br J Haematol; 1991 Apr; 77(4):550-8. PubMed ID: 2025581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure.
    Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC
    Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.